Profile data is unavailable for this security.
About the company
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
- Revenue in HKD (TTM)4.79bn
- Net income in HKD1.90bn
- Incorporated2021
- Employees1.51k
- LocationGiant Biogene Holding Co LtdShanglin Yuan 7th RoadChang'An District, No. 1855XI'AN ChinaCHN
- Websitehttp://www.xajuzi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emami Ltd | 3.40bn | 712.82m | 25.90bn | 3.29k | 36.34 | 10.68 | 29.49 | 7.62 | 17.70 | 17.70 | 84.38 | 60.22 | 1.07 | 3.28 | 7.62 | 11,201,660.00 | 22.25 | 20.43 | 29.71 | 27.91 | 68.24 | 65.56 | 20.87 | 18.75 | 1.57 | 41.96 | 0.0275 | 53.89 | 5.06 | 5.85 | 13.13 | 19.00 | -21.85 | 14.87 |
| Lion Corp | 20.42bn | 923.36m | 25.95bn | 7.55k | 27.64 | 1.80 | 12.42 | 1.27 | 65.93 | 65.93 | 1,459.94 | 1,014.74 | 0.868 | 3.71 | 5.65 | 54,016,950.00 | 4.48 | 5.63 | 6.59 | 8.93 | 45.82 | 47.60 | 5.17 | 6.45 | 1.28 | -- | 0.0959 | 31.01 | 3.31 | 2.88 | -33.34 | -10.60 | 9.21 | 5.39 |
| Hengan International Group Company Ltd | 25.16bn | 3.21bn | 26.50bn | 24.00k | 8.17 | 1.18 | 6.29 | 1.05 | 2.79 | 2.79 | 21.88 | 19.29 | 0.4935 | 4.01 | 8.68 | 1,093,900.00 | 6.29 | 7.70 | 13.60 | 15.91 | 34.87 | 37.14 | 12.75 | 14.79 | 1.10 | 12.23 | 0.4955 | 65.99 | 5.09 | 2.99 | 45.46 | -5.92 | 15.95 | -9.05 |
| Gillette India Limited | 2.53bn | 417.04m | 27.91bn | 523.00 | 66.93 | -- | 56.67 | 11.01 | 138.72 | 138.72 | 843.17 | -- | -- | -- | -- | 52,530,590.00 | -- | 20.47 | -- | 33.03 | 58.56 | 52.87 | 16.45 | 14.45 | -- | 62.76 | -- | 90.38 | 6.30 | 7.18 | 15.75 | 10.24 | -2.28 | 15.39 |
| Unilever Indonesia Tbk PT | 17.43bn | 1.78bn | 33.78bn | 4.45k | 19.01 | 20.04 | 15.07 | 1.94 | 94.94 | 94.94 | 931.14 | 90.07 | 2.00 | 7.60 | 11.06 | 7,740,902,000.00 | 20.42 | 31.40 | 56.69 | 88.33 | 48.68 | 50.45 | 10.20 | 14.85 | 0.2927 | 76.63 | 0.212 | 101.38 | -6.33 | -1.58 | -10.51 | -11.97 | -4.74 | -9.99 |
| Proya Cosmetics Co Ltd | 11.41bn | 1.55bn | 39.46bn | 2.97k | 25.80 | 7.59 | -- | 3.46 | 3.59 | 3.59 | 26.38 | 12.21 | 1.48 | 2.94 | 44.81 | 3,575,240.00 | 20.60 | 15.54 | 28.47 | 21.61 | 68.52 | 66.58 | 13.92 | 12.83 | 2.49 | -- | 0.1538 | 30.15 | 39.45 | 30.41 | 46.06 | 32.97 | -4.80 | 42.52 |
| Procter & Gamble Hygiene & Health Care | 3.88bn | 623.90m | 47.32bn | 439.00 | 75.85 | -- | 70.25 | 12.20 | 208.32 | 208.32 | 1,294.64 | -- | -- | -- | -- | 95,729,160.00 | -- | 33.42 | -- | 62.37 | 62.16 | 49.77 | 16.09 | 16.20 | -- | 34.89 | -- | 85.09 | 7.35 | 7.37 | -0.4601 | 10.00 | 22.65 | 17.25 |
| Giant Biogene Holding Co Ltd | 4.79bn | 1.90bn | 50.28bn | 1.51k | 25.43 | 7.83 | 25.97 | 10.49 | 1.92 | 1.92 | 4.86 | 6.24 | 0.7649 | 2.96 | 31.08 | 4,118,856.00 | 30.24 | -- | 36.89 | -- | 82.74 | -- | 39.53 | -- | 3.62 | -- | 0.0002 | -- | 49.05 | -- | 44.88 | -- | -- | -- |
| Shiseido Co Ltd | 48.74bn | 99.50m | 54.89bn | 30.54k | 551.82 | 1.83 | 13.54 | 1.13 | 4.97 | 4.97 | 2,435.08 | 1,498.75 | 0.7625 | 1.45 | 6.71 | 31,872,130.00 | 0.3099 | 2.91 | 0.4583 | 4.39 | 76.26 | 73.51 | 0.4064 | 3.52 | 0.6836 | -- | 0.3466 | 75.17 | -8.84 | -2.33 | -36.41 | -18.75 | -10.63 | 5.92 |
| Colgate-Palmolive (India) Ltd | 5.54bn | 1.36bn | 68.59bn | 2.22k | 50.61 | 44.98 | 45.45 | 12.39 | 54.01 | 54.01 | 220.65 | 60.77 | 1.89 | 5.46 | 34.10 | 27,021,510.00 | 46.22 | 37.35 | 82.27 | 63.15 | 70.10 | 60.82 | 24.48 | 20.89 | 1.08 | 368.18 | 0.0407 | 108.26 | 8.69 | 4.95 | 26.41 | 11.28 | -11.45 | 15.85 |
Data as of Nov 21 2024. Currency figures normalised to Giant Biogene Holding Co Ltd's reporting currency: Hong Kong Dollar HKD
12.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 11 Mar 2024 | 50.07m | 4.87% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 16.16m | 1.57% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 14.64m | 1.42% |
| Rosefinch Fund Management Co., Ltd.as of 30 Jun 2024 | 12.43m | 1.21% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 9.59m | 0.93% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 6.73m | 0.66% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 5.26m | 0.51% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 4.49m | 0.44% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 4.14m | 0.40% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 4.02m | 0.39% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
